COVIDEZE
Live / Registered — Registered (as of 19 Dec 2023)
What this means for you
Registered since 19 Dec 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Dec 2029: the §8 declaration of use).
Record
- Serial number
- 97027288
- Registration number
- 7250074
- Mark type
- Design + words
- Filed
- 14 Sept 2021
- Published for opposition
- 26 Apr 2022
- Registered
- 19 Dec 2023
- Next maintenance filing
- §8 declaration of use, due by 19 Dec 2029 (grace period to 19 Jun 2030)
Goods and services
- Class 005 — Pharmaceuticals: Pain relief medication for the treatment of coronavirus symptoms
Owner
- B&W PHARMACEUTICALS INC., Cleveland, MS, US
- B&W PHARMACEUTICALS INC., Cleveland, MS, US
- B&W PHARMACEUTICALS INC., Cleveland, MS, US
Prosecution history
- 19 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Nov 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Nov 2023 — ASSIGNED TO EXAMINER
- 08 Dec 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Nov 2022 — USE AMENDMENT FILED
- 08 Dec 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Nov 2022 — TEAS STATEMENT OF USE RECEIVED
- 21 Jun 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Apr 2022 — PUBLISHED FOR OPPOSITION
- 06 Apr 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Mar 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 21 Mar 2022 — ASSIGNED TO LIE